Drug development has opened new perspectives for the treatment of pati
ents with psoriasis. Existing treatments have been improved in order t
o maximize clinical efficacy and to minimize side-effects. Recently tw
o new treatments have been introduced for routine treatment: cyclospor
in and calcipotriol. Experimental treatments are in various phases of
development. The aim of the present review is to highlight the most im
portant new developments in the treatment of psoriasis.